Skip to main content
. 2014 Jun 17;16(5):441–450. doi: 10.1016/j.neo.2014.04.007

Table 1.

Initial panel of candidate TD pairs for CRC, showing the percentages of the four gene expression patterns.

TD pairs
Percentages of gene pairs from 70 Asian CRC versus 12 non-cancerous tissues that were expressed 2-fold or more
Gene 1 Gene 2 (up, up) pattern (up, down) pattern (down, up) pattern (down, down) pattern Permutation P value* FDR
FEN1 RAD54B 0.67 0.00 0.00 0.00 0.0001 1×10- 5
BRCA2 PARP1 0.34 0.00 0.00 0.00 0.0001 1×10- 5
MSH2 POLB 0.33 0.00 0.00 0.00 0.0001 1×10- 5
BRCA1 PARP1 0.26 0.00 0.00 0.00 0.0001 1×10- 5
MYC AURKB 0.17 0.00 0.00 0.00 0.0001 1×10- 5
RB1 SKP2 0.06 0.00 0.00 0.00 0.0002 2×10- 5
CSNK1E CTNNB1 0.03 0.00 0.00 0.00 0.0001 1×10- 5
BCR WNT5A 0.03 0.01 0.00 0.00 0.0001 1×10- 5
KRAS SLKRAS§ 0.01 0.00 0.00 0.00 0.0001 ~ 0.7200 1×10- 5 ~ 0.0303
TP53 SGK2 0.00 0.33 0.00 0.20 0.0004 3×10- 5
KRAS SLKRAS 0.00 0.01 0.00 0.00 0.0001 ~ 0.8540 1×10- 5 ~ 0.0351
PTEN PARP1 0.00 0.00 0.01 0.00 0.0001 1×10- 5
ABL1 WNT5A 0.00 0.00 0.01 0.00 0.0043 0.0003
*

This P value was for the highest percentage of the four patterns computed by permutation test with 10,000 repeats.

FDR was estimated by q-value.

The four fractions are computed from gene pairs that were 2-fold differentially expressed, thus they might not sum up to 100%.

§

57 verified KRAS SL pairs were identified in the (up, up) pattern.

19 verified KRAS SL pairs were identified in the (up, down) pattern.